Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Mar 4;46(4):832. doi: 10.1007/s00134-020-05986-8

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin

J J Rouby 1,, C Sole-Lleonart 2,3, J Rello 4,5,6; the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia
PMCID: PMC7222143  PMID: 32130461

Correction to: Intensive Care Med 10.1007/s00134-019-05890-w

The original version of this article unfortunately contained a mistake. There was a typographical error in figure 1: “Nebulization time ≤ 30 min” (first light blue square) should be replaced by “Nebulization time ≤ 90 min”. The authors apologize for the mistake.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

J. J. Rouby, Email: jjrouby@invivo.edu

the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia:

Antoine Monsel, Jean-Michel Constantin, Adrien Bouglé, Stijn Blot, Garyphalia Poulakou, Konstantinos Pontikis, Anna Kyriakoudi, Antonia Koutsoukou, George Dimopoulos, Christina Routsi, Kostoula Arvaniti, Jose Manuel Pereira, Timothy Felton, Jayesh Dhanani, Jason Roberts, Matteo Bassetti, Tobias Welte, Jonathan Dugernier, Pierre-François Laterre, Stephan Ehrmann, Matthieu Boisson, Olivier Mimoz, Marc Leone, Lucy B. Palmer, Jérôme Pugin, Jie-ming Qu, Ying-gang Zhu, and Xuelian Liao


Articles from Intensive Care Medicine are provided here courtesy of Nature Publishing Group

RESOURCES